{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 464387259
| IUPAC_name = ''N''-[(2''S'')-4-(4-acetamido-4-phenylpiperidin-1-yl)- 2-(3,4-dichlorophenyl)butyl]-''N''-methylbenzamide
| image = Saredutant.svg
| width = 250

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 142001-63-6
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 104974
| IUPHAR_ligand = 2111
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 94726
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 308148

<!--Chemical data-->
| C=31 | H=35 | Cl=2 | N=3 | O=2
| molecular_weight = 552.5345 g/mol
| smiles = Clc1ccc(cc1Cl)[C@H](CCN3CCC(c2ccccc2)(NC(=O)C)CC3)CN(C(=O)c4ccccc4)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C31H35Cl2N3O2/c1-23(37)34-31(27-11-7-4-8-12-27)16-19-36(20-17-31)18-15-26(25-13-14-28(32)29(33)21-25)22-35(2)30(38)24-9-5-3-6-10-24/h3-14,21,26H,15-20,22H2,1-2H3,(H,34,37)/t26-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = PGKXDIMONUAMFR-AREMUKBSSA-N
}}

'''Saredutant''' ('''SR-48,968''') is a [[drug]] that acts as a [[Tachykinin receptor 2|NK<sub>2</sub> receptor]] [[receptor antagonist|antagonist]]. It was under development by [[Sanofi-Aventis]] as a novel [[antidepressant]] and [[anxiolytic]] and made it to [[phase III]] [[clinical trial]]s. However, in May 2009, Sanofi-Aventis published its quarterly results and announced the cessation of 14 research/development projects, among which was saredutant for the treatment of [[major depressive disorder]].<ref>http://www.sanofi-aventis.com/binaries/Lettre18_FR_Web_acc_tcm29-25341.pdf Letter to the stockholders of Sanofi-Aventis on May 2009</ref>

==See also==
* [[GR-159,897]]
* [[Ibodutant]]
* [[Nepadutant]]

==References==
{{Reflist|2}}


{{Antidepressants}}
{{Anxiolytics}}
{{Neurokinin receptor modulators}}

[[Category:Antidepressants]]
[[Category:Anxiolytics]]
[[Category:NK2 receptor antagonists]]
[[Category:Acetanilides]]
[[Category:Piperidines]]
[[Category:Chloroarenes]]
[[Category:Benzamides]]
[[Category:Experimental drugs]]


{{nervous-system-drug-stub}}